Cryo-Cell International Inc (CCEL)
9.13
-0.25
(-2.67%)
USD |
NYAM |
May 16, 16:00
9.13
0.00 (0.00%)
After-Hours: 20:00
Cryo-Cell International Cash from Financing (Quarterly): 0.539M for Feb. 29, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.539M |
| November 30, 2023 | -1.541M |
| August 31, 2023 | 0.9039M |
| May 31, 2023 | -0.6632M |
| February 28, 2023 | -0.7728M |
| November 30, 2022 | -5.566M |
| August 31, 2022 | 8.657M |
| May 31, 2022 | -1.372M |
| February 28, 2022 | -1.572M |
| November 30, 2021 | -0.8143M |
| August 31, 2021 | -0.775M |
| May 31, 2021 | 0.0997M |
| February 28, 2021 | -1.583M |
| November 30, 2020 | -0.775M |
| August 31, 2020 | -2.72M |
| May 31, 2020 | -0.775M |
| February 29, 2020 | -0.734M |
| November 30, 2019 | -1.767M |
| August 31, 2019 | -1.82M |
| May 31, 2019 | -0.775M |
| February 28, 2019 | -0.7693M |
| November 30, 2018 | -1.775M |
| August 31, 2018 | 8.48M |
| May 31, 2018 | -0.4973M |
| February 28, 2018 | -0.4978M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.4867M |
| August 31, 2017 | -1.193M |
| May 31, 2017 | -0.7973M |
| February 28, 2017 | -0.5552M |
| November 30, 2016 | -1.017M |
| August 31, 2016 | -3.585M |
| May 31, 2016 | -0.1851M |
| February 29, 2016 | -0.4838M |
| November 30, 2015 | -0.3175M |
| August 31, 2015 | -1.989M |
| May 31, 2015 | -0.9134M |
| February 28, 2015 | -0.039M |
| November 30, 2014 | -0.3682M |
| August 31, 2014 | -0.8651M |
| May 31, 2014 | -0.9067M |
| February 28, 2014 | -0.4519M |
| November 30, 2013 | -0.0666M |
| August 31, 2013 | -0.001M |
| May 31, 2013 | -0.4091M |
| February 28, 2013 | -0.247M |
| November 30, 2012 | -0.4262M |
| August 31, 2012 | -0.5483M |
| May 31, 2012 | -0.923M |
| February 29, 2012 | -3.054M |
| November 30, 2011 | 0.0582M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.566M
Minimum
Nov 2022
8.657M
Maximum
Aug 2022
-0.6913M
Average
-0.775M
Median
Cash from Financing (Quarterly) Benchmarks
| American Shared Hospital Services | 2.31M |
| Novo Integrated Sciences Inc | 0.0032M |
| Astrana Health Inc | 106.35M |
| P3 Health Partners Inc | 11.40M |
| Biote Corp | -5.409M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.3569M |
| Cash from Investing (Quarterly) | -0.341M |
| Free Cash Flow | -0.8021M |
| Free Cash Flow Per Share (Quarterly) | -0.0987 |
| Free Cash Flow to Equity (Quarterly) | -1.529M |
| Free Cash Flow to Firm (Quarterly) | -0.635M |
| Free Cash Flow Yield | -1.06% |